Literature DB >> 34955334

Arterial Stiffness and Vascular Load in HFpEF: Differences Among Women and Men.

Emily S Lau1, Lindsay G Panah2, Emily K Zern1, Elizabeth E Liu1, Robyn Farrell1, Mark W Schoenike1, Mayooran Namasivayam3, Timothy W Churchill1, Lisa Curreri1, Rajeev Malhotra4, Matthew Nayor1, Gregory D Lewis1, Jennifer E Ho5.   

Abstract

BACKGROUND: Mechanisms underlying sex differences in heart failure with preserved ejection fraction (HFpEF) are poorly understood. We sought to examine sex differences in measures of arterial stiffness and the association of arterial stiffness measures with left ventricular hemodynamic responses to exercise in men and women.
METHODS: We studied 83 men (mean age 62 years) and 107 women (mean age 59 years) with HFpEF who underwent cardiopulmonary exercise testing with invasive hemodynamic monitoring and arterial stiffness measurement (augmentation pressure [AP], augmentation index [AIx], and aortic pulse pressure [AoPP]). Sex differences were compared using multivariable linear regression. We examined the association of arterial stiffness with abnormal left ventricular diastolic response to exercise, defined as a rise in pulmonary capillary wedge pressure relative to cardiac output (∆PCWP/∆CO) ≥ 2 mmHg/L/min by using logistic regression models.
RESULTS: Women with HFpEF had increased arterial stiffness compared with men. AP was nearly 10 mmHg higher, and AIx was more than 10% higher in women compared with men (P < 0.0001 for both). Arterial stiffness measures were associated with a greater pulmonary capillary wedge pressure response to exercise, particularly among women. A 1-standard deviation higher AP was associated with > 3-fold increased odds of abnormal diastolic exercise response (AP: OR 3.16, 95% CI 1.34-7.42; P = 0.008 [women] vs OR 2.07, 95% CI 0.95-5.49; P = 0.15 [men]) with similar findings for AIx and AoPP.
CONCLUSIONS: Arterial stiffness measures are significantly higher in women with HFpEF than in men and are associated with abnormally steep increases in pulmonary capillary wedge pressure with exercise, particularly in women. Arterial stiffness may preferentially contribute to abnormal diastolic function during exercise in women with HFpEF compared with men.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Sex; arterial stiffness; heart failure with preserved ejection fraction

Mesh:

Year:  2021        PMID: 34955334      PMCID: PMC8840989          DOI: 10.1016/j.cardfail.2021.10.019

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  33 in total

Review 1.  Obesity, arterial stiffness, and cardiovascular risk.

Authors:  Michel E Safar; Sébastien Czernichow; Jacques Blacher
Journal:  J Am Soc Nephrol       Date:  2006-04       Impact factor: 10.121

Review 2.  Pulsatile arterial haemodynamics in heart failure.

Authors:  Thomas Weber; Julio A Chirinos
Journal:  Eur Heart J       Date:  2018-11-14       Impact factor: 29.983

3.  Obesity is associated with increased arterial stiffness from adolescence until old age.

Authors:  Pantelis E Zebekakis; Tim Nawrot; Lutgarde Thijs; Elisabeth J Balkestein; Janneke van der Heijden-Spek; Luc M Van Bortel; Harry A Struijker-Boudier; Michel E Safar; Jan A Staessen
Journal:  J Hypertens       Date:  2005-10       Impact factor: 4.844

4.  Training for a First-Time Marathon Reverses Age-Related Aortic Stiffening.

Authors:  Anish N Bhuva; Andrew D'Silva; Camilla Torlasco; Siana Jones; Niromila Nadarajan; Jet Van Zalen; Nish Chaturvedi; Guy Lloyd; Sanjay Sharma; James C Moon; Alun D Hughes; Charlotte H Manisty
Journal:  J Am Coll Cardiol       Date:  2020-01-07       Impact factor: 24.094

5.  Sex Differences in Heart Failure With Preserved Ejection Fraction Pathophysiology: A Detailed Invasive Hemodynamic and Echocardiographic Analysis.

Authors:  Anna L Beale; Shane Nanayakkara; Louise Segan; Justin A Mariani; Micha T Maeder; Vanessa van Empel; Donna Vizi; Shona Evans; Carolyn S P Lam; David M Kaye
Journal:  JACC Heart Fail       Date:  2019-03       Impact factor: 12.035

6.  Relation of brachial and digital measures of vascular function in the community: the Framingham heart study.

Authors:  Naomi M Hamburg; Joseph Palmisano; Martin G Larson; Lisa M Sullivan; Birgitta T Lehman; Ramachandran S Vasan; Daniel Levy; Gary F Mitchell; Joseph A Vita; Emelia J Benjamin
Journal:  Hypertension       Date:  2011-01-24       Impact factor: 10.190

7.  Arterial Stiffening With Exercise in Patients With Heart Failure and Preserved Ejection Fraction.

Authors:  Yogesh N V Reddy; Mads J Andersen; Masaru Obokata; Katlyn E Koepp; Garvan C Kane; Vojtech Melenovsky; Thomas P Olson; Barry A Borlaug
Journal:  J Am Coll Cardiol       Date:  2017-07-11       Impact factor: 24.094

8.  Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial.

Authors:  Carolyn S P Lam; Peter E Carson; Inder S Anand; Thomas S Rector; Michael Kuskowski; Michel Komajda; Robert S McKelvie; John J McMurray; Michael R Zile; Barry M Massie; Dalane W Kitzman
Journal:  Circ Heart Fail       Date:  2012-08-10       Impact factor: 8.790

9.  Longitudinal tracking of left ventricular mass over the adult life course: clinical correlates of short- and long-term change in the framingham offspring study.

Authors:  Wolfgang Lieb; Vanessa Xanthakis; Lisa M Sullivan; Jayashri Aragam; Michael J Pencina; Martin G Larson; Emelia J Benjamin; Ramachandran S Vasan
Journal:  Circulation       Date:  2009-06-08       Impact factor: 29.690

10.  Systolic Blood Pressure in Heart Failure With Preserved Ejection Fraction Treated With Sacubitril/Valsartan.

Authors:  Senthil Selvaraj; Brian L Claggett; Michael Böhm; Stefan D Anker; Muthiah Vaduganathan; Faiez Zannad; Burkert Pieske; Carolyn S P Lam; Inder S Anand; Victor C Shi; Martin P Lefkowitz; John J V McMurray; Scott D Solomon
Journal:  J Am Coll Cardiol       Date:  2020-03-16       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.